CN114213532A - 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 - Google Patents
高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 Download PDFInfo
- Publication number
- CN114213532A CN114213532A CN202111522402.4A CN202111522402A CN114213532A CN 114213532 A CN114213532 A CN 114213532A CN 202111522402 A CN202111522402 A CN 202111522402A CN 114213532 A CN114213532 A CN 114213532A
- Authority
- CN
- China
- Prior art keywords
- gly
- ser
- ala
- scfv
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000702626 Infectious bursal disease virus Species 0.000 title claims abstract description 25
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 34
- 108020004414 DNA Proteins 0.000 claims description 25
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 102000053602 DNA Human genes 0.000 claims description 14
- 235000013330 chicken meat Nutrition 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 208000027312 Bursal disease Diseases 0.000 claims description 7
- 230000002458 infectious effect Effects 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 2
- 125000000539 amino acid group Chemical group 0.000 claims 9
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
- 238000002965 ELISA Methods 0.000 abstract description 10
- 238000002819 bacterial display Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 101500001532 Avian infectious bursal disease virus Capsid protein VP2 Proteins 0.000 abstract description 2
- 230000004186 co-expression Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract description 2
- 238000006386 neutralization reaction Methods 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 12
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 12
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 11
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 11
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 10
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 9
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 8
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 8
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 8
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 8
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 8
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 8
- TUIOUEWKFFVNLH-DCAQKATOSA-N Leu-Val-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O TUIOUEWKFFVNLH-DCAQKATOSA-N 0.000 description 8
- 108010008355 arginyl-glutamine Proteins 0.000 description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 8
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 8
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 7
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 7
- 108010079364 N-glycylalanine Proteins 0.000 description 7
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 7
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 7
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 7
- 108010061238 threonyl-glycine Proteins 0.000 description 7
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 6
- VNFSAYFQLXPHPY-CIQUZCHMSA-N Ala-Thr-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNFSAYFQLXPHPY-CIQUZCHMSA-N 0.000 description 6
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 6
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 6
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 6
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 6
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 6
- 108010050848 glycylleucine Proteins 0.000 description 6
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 5
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 5
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 5
- 241000880493 Leptailurus serval Species 0.000 description 5
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 5
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 5
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 5
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 5
- ULHJJQYGMWONTD-HKUYNNGSSA-N Tyr-Gly-Trp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ULHJJQYGMWONTD-HKUYNNGSSA-N 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 4
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 4
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 4
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 4
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 4
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 4
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 4
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 4
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 4
- ADZGCWWDPFDHCY-ZETCQYMHSA-N Gly-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 ADZGCWWDPFDHCY-ZETCQYMHSA-N 0.000 description 4
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 4
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 4
- RPZFUIQVAPZLRH-GHCJXIJMSA-N Ile-Asp-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O)N RPZFUIQVAPZLRH-GHCJXIJMSA-N 0.000 description 4
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 4
- JZBVBOKASHNXAD-NAKRPEOUSA-N Ile-Val-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N JZBVBOKASHNXAD-NAKRPEOUSA-N 0.000 description 4
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 4
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 4
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 4
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 4
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 4
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 4
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 4
- MWMKFWJYRRGXOR-ZLUOBGJFSA-N Ser-Ala-Asn Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(N)=O)C)CO MWMKFWJYRRGXOR-ZLUOBGJFSA-N 0.000 description 4
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 4
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 4
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 4
- DIPIPFHFLPTCLK-LOKLDPHHSA-N Thr-Gln-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O DIPIPFHFLPTCLK-LOKLDPHHSA-N 0.000 description 4
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 4
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 4
- OZUJUVFWMHTWCZ-HOCLYGCPSA-N Trp-Gly-His Chemical compound N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O OZUJUVFWMHTWCZ-HOCLYGCPSA-N 0.000 description 4
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 4
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 4
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 4
- 108010038633 aspartylglutamate Proteins 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 4
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- XTHUKRLJRUVVBF-WHFBIAKZSA-N Cys-Gly-Ser Chemical compound SC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O XTHUKRLJRUVVBF-WHFBIAKZSA-N 0.000 description 3
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 3
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 3
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 3
- IROABALAWGJQGM-OALUTQOASA-N Gly-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)CN IROABALAWGJQGM-OALUTQOASA-N 0.000 description 3
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 3
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 3
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 3
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 3
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 3
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 3
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 3
- MMTOHPRBJKEZHT-BWBBJGPYSA-N Thr-Cys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O MMTOHPRBJKEZHT-BWBBJGPYSA-N 0.000 description 3
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 3
- CFSSLXZJEMERJY-NRPADANISA-N Val-Gln-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O CFSSLXZJEMERJY-NRPADANISA-N 0.000 description 3
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 3
- 108010081404 acein-2 Proteins 0.000 description 3
- 108010060035 arginylproline Proteins 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010036413 histidylglycine Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 108010031719 prolyl-serine Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 108010003137 tyrosyltyrosine Proteins 0.000 description 3
- 108010073969 valyllysine Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 2
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 2
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 2
- RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 2
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 2
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 2
- ZVTDYGWRRPMFCL-WFBYXXMGSA-N Asp-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N ZVTDYGWRRPMFCL-WFBYXXMGSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- MADFVRSKEIEZHZ-DCAQKATOSA-N Gln-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N MADFVRSKEIEZHZ-DCAQKATOSA-N 0.000 description 2
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 2
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 2
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 2
- UAELWXJFLZBKQS-WHOFXGATSA-N Ile-Phe-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O UAELWXJFLZBKQS-WHOFXGATSA-N 0.000 description 2
- RKQAYOWLSFLJEE-SVSWQMSJSA-N Ile-Thr-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O)N RKQAYOWLSFLJEE-SVSWQMSJSA-N 0.000 description 2
- LAGPXKYZCCTSGQ-JYJNAYRXSA-N Leu-Glu-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LAGPXKYZCCTSGQ-JYJNAYRXSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 2
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 2
- NCZIQZYZPUPMKY-PPCPHDFISA-N Lys-Ile-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NCZIQZYZPUPMKY-PPCPHDFISA-N 0.000 description 2
- VSJAPSMRFYUOKS-IUCAKERBSA-N Met-Pro-Gly Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O VSJAPSMRFYUOKS-IUCAKERBSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 2
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 2
- OWQXAJQZLWHPBH-FXQIFTODSA-N Pro-Ser-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O OWQXAJQZLWHPBH-FXQIFTODSA-N 0.000 description 2
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 2
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 2
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 2
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 2
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 2
- OSFZCEQJLWCIBG-BZSNNMDCSA-N Ser-Tyr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSFZCEQJLWCIBG-BZSNNMDCSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 2
- IRKWVRSEQFTGGV-VEVYYDQMSA-N Thr-Asn-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IRKWVRSEQFTGGV-VEVYYDQMSA-N 0.000 description 2
- FLPZMPOZGYPBEN-PPCPHDFISA-N Thr-Leu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLPZMPOZGYPBEN-PPCPHDFISA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- XVHAUVJXBFGUPC-RPTUDFQQSA-N Thr-Tyr-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XVHAUVJXBFGUPC-RPTUDFQQSA-N 0.000 description 2
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 2
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 2
- DANHCMVVXDXOHN-SRVKXCTJSA-N Tyr-Asp-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DANHCMVVXDXOHN-SRVKXCTJSA-N 0.000 description 2
- FQNUWOHNGJWNLM-QWRGUYRKSA-N Tyr-Cys-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FQNUWOHNGJWNLM-QWRGUYRKSA-N 0.000 description 2
- LTSIAOZUVISRAQ-QWRGUYRKSA-N Tyr-Gly-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)O LTSIAOZUVISRAQ-QWRGUYRKSA-N 0.000 description 2
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010033719 glycyl-histidyl-glycine Proteins 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 108010038745 tryptophylglycine Proteins 0.000 description 2
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 1
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 1
- YSMPVONNIWLJML-FXQIFTODSA-N Ala-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O YSMPVONNIWLJML-FXQIFTODSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- LDLSENBXQNDTPB-DCAQKATOSA-N Ala-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LDLSENBXQNDTPB-DCAQKATOSA-N 0.000 description 1
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 1
- VEAPAYQQLSEKEM-GUBZILKMSA-N Ala-Met-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O VEAPAYQQLSEKEM-GUBZILKMSA-N 0.000 description 1
- FVNAUOZKIPAYNA-BPNCWPANSA-N Ala-Met-Tyr Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FVNAUOZKIPAYNA-BPNCWPANSA-N 0.000 description 1
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 1
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 1
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 1
- ZTKHZAXGTFXUDD-VEVYYDQMSA-N Arg-Asn-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZTKHZAXGTFXUDD-VEVYYDQMSA-N 0.000 description 1
- PQWTZSNVWSOFFK-FXQIFTODSA-N Arg-Asp-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)CN=C(N)N PQWTZSNVWSOFFK-FXQIFTODSA-N 0.000 description 1
- CFGHCPUPFHWMCM-FDARSICLSA-N Arg-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N CFGHCPUPFHWMCM-FDARSICLSA-N 0.000 description 1
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 1
- AUZAXCPWMDBWEE-HJGDQZAQSA-N Arg-Thr-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O AUZAXCPWMDBWEE-HJGDQZAQSA-N 0.000 description 1
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 1
- JJGRJMKUOYXZRA-LPEHRKFASA-N Asn-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O JJGRJMKUOYXZRA-LPEHRKFASA-N 0.000 description 1
- RCENDENBBJFJHZ-ACZMJKKPSA-N Asn-Asn-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RCENDENBBJFJHZ-ACZMJKKPSA-N 0.000 description 1
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 1
- QISZHYWZHJRDAO-CIUDSAMLSA-N Asn-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N QISZHYWZHJRDAO-CIUDSAMLSA-N 0.000 description 1
- ANPFQTJEPONRPL-UGYAYLCHSA-N Asn-Ile-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O ANPFQTJEPONRPL-UGYAYLCHSA-N 0.000 description 1
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 1
- RLHANKIRBONJBK-IHRRRGAJSA-N Asn-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N RLHANKIRBONJBK-IHRRRGAJSA-N 0.000 description 1
- FMNBYVSGRCXWEK-FOHZUACHSA-N Asn-Thr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O FMNBYVSGRCXWEK-FOHZUACHSA-N 0.000 description 1
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 1
- DPSUVAPLRQDWAO-YDHLFZDLSA-N Asn-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)N DPSUVAPLRQDWAO-YDHLFZDLSA-N 0.000 description 1
- FAEIQWHBRBWUBN-FXQIFTODSA-N Asp-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N FAEIQWHBRBWUBN-FXQIFTODSA-N 0.000 description 1
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- HAFCJCDJGIOYPW-WDSKDSINSA-N Asp-Gly-Gln Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O HAFCJCDJGIOYPW-WDSKDSINSA-N 0.000 description 1
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 1
- HXVILZUZXFLVEN-DCAQKATOSA-N Asp-Met-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O HXVILZUZXFLVEN-DCAQKATOSA-N 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- XYPJXLLXNSAWHZ-SRVKXCTJSA-N Asp-Ser-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XYPJXLLXNSAWHZ-SRVKXCTJSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 1
- HQZGVYJBRSISDT-BQBZGAKWSA-N Cys-Gly-Arg Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQZGVYJBRSISDT-BQBZGAKWSA-N 0.000 description 1
- OXOQBEVULIBOSH-ZDLURKLDSA-N Cys-Gly-Thr Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O OXOQBEVULIBOSH-ZDLURKLDSA-N 0.000 description 1
- NXQCSPVUPLUTJH-WHFBIAKZSA-N Cys-Ser-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O NXQCSPVUPLUTJH-WHFBIAKZSA-N 0.000 description 1
- VRJZMZGGAKVSIQ-SRVKXCTJSA-N Cys-Tyr-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VRJZMZGGAKVSIQ-SRVKXCTJSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VZRAXPGTUNDIDK-GUBZILKMSA-N Gln-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VZRAXPGTUNDIDK-GUBZILKMSA-N 0.000 description 1
- IHSGESFHTMFHRB-GUBZILKMSA-N Gln-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O IHSGESFHTMFHRB-GUBZILKMSA-N 0.000 description 1
- BYKZWDGMJLNFJY-XKBZYTNZSA-N Gln-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)O BYKZWDGMJLNFJY-XKBZYTNZSA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 1
- GNPVTZJUUBPZKW-WDSKDSINSA-N Gly-Gln-Ser Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GNPVTZJUUBPZKW-WDSKDSINSA-N 0.000 description 1
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- FCKPEGOCSVZPNC-WHOFXGATSA-N Gly-Ile-Phe Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FCKPEGOCSVZPNC-WHOFXGATSA-N 0.000 description 1
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 1
- DBJYVKDPGIFXFO-BQBZGAKWSA-N Gly-Met-Ala Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O DBJYVKDPGIFXFO-BQBZGAKWSA-N 0.000 description 1
- HHRODZSXDXMUHS-LURJTMIESA-N Gly-Met-Gly Chemical compound CSCC[C@H](NC(=O)C[NH3+])C(=O)NCC([O-])=O HHRODZSXDXMUHS-LURJTMIESA-N 0.000 description 1
- GGAPHLIUUTVYMX-QWRGUYRKSA-N Gly-Phe-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)C[NH3+])CC1=CC=CC=C1 GGAPHLIUUTVYMX-QWRGUYRKSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 1
- IMRNSEPSPFQNHF-STQMWFEESA-N Gly-Ser-Trp Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O IMRNSEPSPFQNHF-STQMWFEESA-N 0.000 description 1
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 1
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 1
- CISBRYJZMFWOHJ-JBDRJPRFSA-N Ile-Ala-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)N CISBRYJZMFWOHJ-JBDRJPRFSA-N 0.000 description 1
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 1
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 1
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 1
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 1
- DZMWFIRHFFVBHS-ZEWNOJEFSA-N Ile-Tyr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N DZMWFIRHFFVBHS-ZEWNOJEFSA-N 0.000 description 1
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- DKTNGXVSCZULPO-YUMQZZPRSA-N Lys-Gly-Cys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CS)C(O)=O DKTNGXVSCZULPO-YUMQZZPRSA-N 0.000 description 1
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 1
- MIXPUVSPPOWTCR-FXQIFTODSA-N Met-Ser-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MIXPUVSPPOWTCR-FXQIFTODSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ALHULIGNEXGFRM-QWRGUYRKSA-N Phe-Cys-Gly Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)CC1=CC=CC=C1 ALHULIGNEXGFRM-QWRGUYRKSA-N 0.000 description 1
- IILUKIJNFMUBNF-IHRRRGAJSA-N Phe-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O IILUKIJNFMUBNF-IHRRRGAJSA-N 0.000 description 1
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 1
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 1
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 1
- MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- NERYDXBVARJIQS-JYBASQMISA-N Ser-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N)O NERYDXBVARJIQS-JYBASQMISA-N 0.000 description 1
- GSCVDSBEYVGMJQ-SRVKXCTJSA-N Ser-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)O GSCVDSBEYVGMJQ-SRVKXCTJSA-N 0.000 description 1
- QYBRQMLZDDJBSW-AVGNSLFASA-N Ser-Tyr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYBRQMLZDDJBSW-AVGNSLFASA-N 0.000 description 1
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 1
- HKHCTNFKZXAMIF-KKUMJFAQSA-N Ser-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=C(O)C=C1 HKHCTNFKZXAMIF-KKUMJFAQSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- PXQUBKWZENPDGE-CIQUZCHMSA-N Thr-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)N PXQUBKWZENPDGE-CIQUZCHMSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- JQAWYCUUFIMTHE-WLTAIBSBSA-N Thr-Gly-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JQAWYCUUFIMTHE-WLTAIBSBSA-N 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- HPQHHRLWSAMMKG-KATARQTJSA-N Thr-Lys-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)N)O HPQHHRLWSAMMKG-KATARQTJSA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- NDLHSJWPCXKOGG-VLCNGCBASA-N Thr-Trp-Tyr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N)O NDLHSJWPCXKOGG-VLCNGCBASA-N 0.000 description 1
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 1
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- PFCQMGDEHBTIIM-JYBASQMISA-N Trp-Cys-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CNC2=C1 PFCQMGDEHBTIIM-JYBASQMISA-N 0.000 description 1
- SNWIAPVRCNYFNI-SZMVWBNQSA-N Trp-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SNWIAPVRCNYFNI-SZMVWBNQSA-N 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- DLZKEQQWXODGGZ-KWQFWETISA-N Tyr-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KWQFWETISA-N 0.000 description 1
- NSTPFWRAIDTNGH-BZSNNMDCSA-N Tyr-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NSTPFWRAIDTNGH-BZSNNMDCSA-N 0.000 description 1
- CGDZGRLRXPNCOC-SRVKXCTJSA-N Tyr-Cys-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CGDZGRLRXPNCOC-SRVKXCTJSA-N 0.000 description 1
- HKYTWJOWZTWBQB-AVGNSLFASA-N Tyr-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HKYTWJOWZTWBQB-AVGNSLFASA-N 0.000 description 1
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229940125644 antibody drug Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000001669 bursa of fabricius Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960005030 other vaccine in atc Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108010025488 pinealon Proteins 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- -1 pplication Species 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 108010005834 tyrosyl-alanyl-glycine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Abstract
本发明公开了几种高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用。本发明提供的几种scFv抗体，包括由重链可变区、轻链可变区以及它们之间的连接区组成；本发明利用抗原‑抗体共表达的细菌展示技术筛选获得了8株scFv抗体，并且与IBDV VP2蛋白和不同的IBDV病毒株具有高亲和力，其可以通过构建突变库筛选出具有高亲和力和中和活性的scFv抗体，用于防治IBD；其也可以用于ELISA法检测IBDV病原。
Description
技术领域
本发明涉及高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用，属于生物技术领域。
背景技术
鸡传染性法氏囊病(Infectious Bursal Disease，IBD)是由鸡传染性法氏囊病毒(Infectious Bursal Disease Virus，IBDV)引起的一种急性、高度接触性传染病， IBDV主要侵害3-12周龄的雏鸡和青年鸡，损伤鸡的中枢免疫器官——法氏囊。具有传播速度快、传染性强、感染率及死亡率均高的特点。该病目前在全球范围内均有分布，是养禽业最重要疾病之一，并且因免疫失败而造成的经济损失巨大。
IBDV可在雏鸡法氏囊中的淋巴细胞，尤其是B淋巴细胞中迅速繁殖，导致免疫抑制,从而可增强机体对其它病原体的易感性并且降低对其它疫苗的反应性。抗体药物目前是有效的治疗药物，高免血清和卵黄抗体在发病早期均可起到良好的效果，但是由于工业化生产可控性差和存在水平传播疾病等原因而受到限制。本发明利用抗原-抗体共表达的细菌展示技术筛选获得了8株具有较高亲和力的抗IBDV的scFv抗体，其可以通过构建突变库筛选出具有高亲和力和中和活性的scFv抗体，用于防治IBD；其也可以用于双抗夹心ELISA法检测病原IBDV的存在。
发明内容
本发明的目的是提供高亲和力的抗鸡传染性法氏囊病毒的scFv抗体及其应用。scFv抗体是由重链可变区、轻链可变区以及它们之间的连接区组成，它们能够与IBDV VP2蛋白高亲和力结合，在治疗或者预防传染性法氏囊病和检测传染性法氏囊病毒的 ELISA试剂盒中具有重要应用。
附图说明
图1为scFv抗体的SDS-PAGE图谱。
图2为ELISA检测scFv抗体对VP2蛋白的特异性和亲和力的结果。
图3为ELISA检测scFv抗体对不同IBDV病毒的特异性和亲和力的结果。
具体实施方式
以下的实施例便于更好地理解本发明，但并不限定本发明。下述实施例中的实验方法，如无特殊说明，均为常规方法。下述实施例中所用的试验材料，如无特殊说明，均为自常规生化试剂商店购买得到的。以下实施例中的定量试验，均设置三次重复实验，结果取平均值。
pET-27b(+)载体：购自Novagen公司，Cat.No.69337-3。大肠杆菌Rosetta：购自Novagen公司，Cat.No.71403-4。鸡传染性法氏囊病活疫苗(Gt株)：哈兽研维科生物公司，编号080012122。鸡传染性法氏囊病中等毒力活疫苗(NF8株)：扬州威克生物工程有限公司，编号101042056。鸡传染性法氏囊病活疫苗(MB株)：ABIC，编号20621150B。鸡传染性法氏囊病活疫苗(B87株)：湖南省中岸生物药业有限公司，编号180022026。
包被液(pH9.6)：取Na2CO3 0.15g、NaHCO3 0.293g，溶于水并用水定容至100mL。
PBS缓冲液：取NaCl 8g、KCl 0.2g、Na2HPO4.12H2O 3.58g、KH2PO4 0.24g，溶于 1L水。
实施例1、几种scFv抗体及其编码基因的获得
1、抗体库的构建
取IBDV免疫后的鸡脾脏，提取RNA后反转录成cDNA。根据GenBank上的抗体序列，设计出克隆抗体可变区的基因引物，以cDNA为模板，使用PCR的方法克隆抗体可变区基因。将VH与VL片段连接成scFv基因并与细菌展示载体pBFD-Ab-VP2进行连接，构建抗IBDV抗原抗体共表达的细菌表面展示文库。VH约380bp、VL约320bp， VH-Tlinker-VL约740bp。
2、抗体库的筛选
收集转化后全部克隆，经IPTG(0.25mmol/L)诱导4h，经EDTA-MgCl2处理，与兔抗VP2蛋白的多克隆抗体(即实施例4制备的多克隆抗体溶液，工作浓度为1:5 000 倍稀释)及FITC标记的羊抗兔二抗(购自sigma公司，工作浓度为1:500倍稀释) 各孵育1h，PBS洗涤后利用流式细胞仪对其进行筛选。
经三轮筛选后得到8个与VP2蛋白具有高结合能力的scFv单克隆抗体，将其分别命名为scFv-11、scFv-12、scFv-13、scFv-14、scFv-15、scFv-16、scFv-17和scFv-18 抗体。
8种scFv抗体的氨基酸序列如序列表的序列1～8所示，其核苷酸序列如序列表的序列9～16所示。
实施例2、8种scFv抗体的制备
1、以实施例1中筛选获得的能够表达8个具有高结合能力的单克隆抗体的质粒为模板，用F1和R1组成的引物分别对8个scFv抗体基因进行PCR扩增，得到PCR扩增产物。
F1：5'–CGCCATATGGCCGTGACGTTGGACGAG-3'；
R1：5'–CCCAAGCTTTTAACCTAGGACGGTCAGGG-3'。
2、用限制性内切酶Nde I和Hind III双酶切步骤1的PCR扩增产物，回收酶切产物。
3、用限制性内切酶Nde I和Hind III双酶切pET-27b(+)载体，回收约5367bp 的载体骨架。
4、将步骤2的酶切产物和步骤3的载体骨架连接，得到重组质粒。根据测序结果，对重组质粒进行结构描述如下：在pET-27b(+)载体的Nde I和Hind III酶切位点之间插入了序列表的序列9～16所示的双链DNA分子。
5、将步骤4得到的重组质粒导入大肠杆菌Rosetta，得到重组菌。
6、将步骤5得到的重组菌接种至含50μg/ml卡那霉素的LB液体培养基，37℃、100r/min振荡培养至OD600nm＝0.3；加入IPTG并使其浓度为0.25mmol/L，37℃、100 r/min振荡培养4h。
7、取15L完成步骤6的培养体系，4℃、4000r/min离心30min并收集菌体沉淀。
8、取步骤7得到的菌体沉淀，用PBS缓冲液重悬，加入溶菌酶溶液(购自Amresco)并使溶菌酶的浓度为1mg/ml，4℃放置1h，然后进行超声破碎(25瓦的功率，3min)， 4℃、10000g离心30min，收集沉淀。
9、使用AKTA Purifier 100蛋白层析系统(购自GE公司)纯化目的蛋白
取步骤8得到的沉淀，用100毫升溶解缓冲液(8mol/L尿素水溶液，pH8.0)充分溶解，然后上样于HiLoad 16/60Superdex75 pg柱子(购自GE公司)，然后用500mL 复性缓冲液(2mol/L尿素水溶液，pH8.0)洗脱并收集过柱后的洗脱液，然后在PBS 缓冲液中透析过夜，得到溶液即为8个scFv抗体溶液。所有步骤均在4℃环境下。8 种scFv抗体溶液的SDS-PAGE图谱见图1，显示约为28kD的条带，与预期相符。
实施例3、ELISA检测几种scFv抗体的亲和力和特异性
一、ELISA检测几种scFv抗体对VP2蛋白的特异性和亲和力
1、用蛋白浓度为10μg/ml的scFv抗体溶液(即实施例2制备的scFv抗体溶液，用包被液调整蛋白浓度)包被酶标板，4℃过夜，然后用PBST缓冲液洗涤3次，每次 2min。
2、每孔加入100μl蛋白浓度为40μg/ml的VP2蛋白溶液，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
3、加入兔抗VP2多克隆抗体，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
4、加入HRP标记的羊抗兔抗体(购自R&D system公司，工作浓度为1:8 000 倍稀释)，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
5、加入TMB底物显色液，37℃避光显色5min。
6、每孔加入50μl 2mol/L的H2SO4水溶液，用酶标仪于波长450nm下检测OD 值。
设置用等体积的PBS缓冲液代替步骤2中的VP2蛋白溶液和步骤3中的兔抗VP2 多克隆抗体的PBS组。步骤1中用蛋白浓度为10μg/ml的scFv抗体溶液包被酶标板时：设置步骤2中不加入VP2蛋白溶液的对照组1，步骤3中不加入兔抗VP2多克隆抗体的对照组2，步骤2中不加入VP2蛋白溶液且步骤3中不加入兔抗VP2多克隆抗体的对照组3，用等体积且等蛋白浓度的BSA溶液代替VP2蛋白溶液的对照组4。
每个处理设置3个复孔。
结果见图2。ELISA结果表明，8种scFv抗体均可以与VP2蛋白特异性结合，具有高亲和力。
二、ELISA检测几种scFv抗体对不同IBDV病毒的特异性和亲和力
1、用蛋白浓度为10μg/ml的scFv抗体溶液(即实施例2制备的scFv抗体溶液，用包被液调整蛋白浓度)包被酶标板，4℃过夜，然后用PBST缓冲液洗涤3次，每次 2min。
2、每孔加入100μl IBDV病毒液(病毒剂量为106.2TCID50)，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
3、加入兔抗VP2多克隆抗体，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
4、加入HRP标记的羊抗兔抗体(购自R&D system公司，工作浓度为1:8 000 倍稀释)，37℃孵育1h，然后用PBST缓冲液洗涤3次，每次2min。
5、加入TMB底物显色液，37℃避光显色5min。
6、每孔加入50μl 2mol/L的H2SO4水溶液，用酶标仪于波长450nm下检测OD 值。
分别采用如下IBDV的毒株进行上述实验：Gt株、NF8株、MB株、B87株。
设置用等体积的PBS缓冲液代替步骤2中的IBDV病毒液和步骤3中的兔抗VP2 多克隆抗体的PBS组。设置步骤2中不加入IBDV病毒液的对照组1，步骤3中不加入兔抗VP2多克隆抗体的对照组2，步骤2中不加入IBDV病毒液且步骤3中不加入兔抗 VP2多克隆抗体的对照组3，用等体积等滴度的新城疫病毒液代替IBDV病毒液的对照组4。
每个处理设置3个复孔。
结果见图3。ELISA结果表明，8种scFv抗体均可以与不同IBDV毒株特异性结合，对不同的IBDV毒株具有不同的亲和力。
序列表
<110> 东北农业大学
<120> 几种高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用
<160> 16
<170> SIPOSequenceListing 1.0
<210> 1
<211> 248
<212> PRT
<213> 鸡(Gallus gallus)
<400> 1
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly
1 5 10 15
Gly Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Thr Met Ser Ser Tyr
20 25 30
Asp Met Leu Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Asn Ala Ala Gly Ser Ser Thr Trp Tyr Ala Thr Ala Val
50 55 60
Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Ala Thr Tyr Phe Cys
85 90 95
Val Lys Ala Gly Gly Gly Cys Ser Gly Tyr Gly Cys Gly Ser His Ala
100 105 110
Gly Arg Ile Asp Ala Trp Gly His Gly Thr Glu Val Ile Val Ser Ser
115 120 125
Ala Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
130 135 140
Ser Ala Leu Thr Gln Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr
145 150 155 160
Val Glu Ile Thr Cys Ser Gly Asp Ser Ser Tyr Tyr Gly Trp Tyr Gln
165 170 175
Gln Lys Ala Pro Gly Ser Ala Pro Val Thr Leu Ile Tyr Asp Asn Thr
180 185 190
Asn Arg Pro Ser Asn Ile Pro Ser Arg Phe Ser Gly Ser Lys Ser Gly
195 200 205
Ser Thr Ala Thr Leu Thr Ile Thr Gly Val Gln Ala Asp Asp Glu Ala
210 215 220
Val Tyr Tyr Cys Gly Ser Ala Asp Ser Ser Thr Ala Thr Phe Gly Ala
225 230 235 240
Gly Thr Thr Leu Thr Val Leu Gly
245
<210> 2
<211> 247
<212> PRT
<213> 鸡(Gallus gallus)
<400> 2
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Arg Gly
1 5 10 15
Ala Leu Ser Leu Val Cys Lys Gly Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Val Ser Gly Ser Gly Gly Ser Thr Ala Tyr Gly Ser Ala Val
50 55 60
Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Ala Thr Tyr Tyr Cys
85 90 95
Ala Lys Thr Ala Ser Tyr Cys Tyr Ser Ala Ala Cys Thr Ala Ala Thr
100 105 110
Ile Asp Ala Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser
115 120 125
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala
130 135 140
Leu Thr Gln Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Lys
145 150 155 160
Ile Thr Cys Ser Gly Gly Gly Ser Tyr Tyr Gly Trp Tyr Gln Gln Lys
165 170 175
Ser Pro Gly Ser Ala Pro Val Thr Val Ile Tyr Asp Asn Asn Gln Arg
180 185 190
Pro Ser Asn Ile Pro Ser Arg Phe Ser Gly Ser Thr Ser Gly Ser Thr
195 200 205
Ser Thr Leu Thr Ile Thr Gly Val Gln Ala Asp Asp Glu Ala Val Tyr
210 215 220
Tyr Cys Gly Ser Tyr Asp Ser Ser Gly Asp Gly Thr Phe Gly Ala Gly
225 230 235 240
Thr Thr Leu Thr Val Leu Gly
245
<210> 3
<211> 248
<212> PRT
<213> 鸡(Gallus gallus)
<400> 3
Ala Val Thr Leu Asp Glu Pro Gly Gly Gly Leu Gln Met Pro Gly Gly
1 5 10 15
Gly Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Asp Phe Ser Ser Tyr
20 25 30
Ala Met Met Trp Val Arg Gln Ala Pro Arg Lys Gly Leu Glu Phe Val
35 40 45
Gly Tyr Val Asn Ile Asp Ser Trp Thr Ala Tyr Gly Ala Ala Val Lys
50 55 60
Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val Arg Leu
65 70 75 80
Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys Ala
85 90 95
Lys Gly Ala Tyr Asn Tyr Cys Gly Arg Asn Tyr Val Asn Thr Gly Cys
100 105 110
Ile Asp Ala Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser
115 120 125
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala
130 135 140
Leu Thr Gln Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Glu
145 150 155 160
Ile Ala Cys Ser Gly Gly Ser Ser Tyr Tyr Gly Trp Phe Gln Gln Lys
165 170 175
Ala Pro Gly Ser Ala Pro Val Thr Val Ile Tyr Asp Asn Thr Asn Arg
180 185 190
Pro Ser Asp Ile Pro Ser Arg Phe Ser Gly Ser Leu Ser Gly Ser Thr
195 200 205
Asn Thr Leu Thr Ile Thr Gly Val Gln Ala Asp Asp Glu Ala Val Tyr
210 215 220
Phe Cys Gly Ser Glu Asp Ser Ser Ser Tyr Ala Gly Ile Phe Gly Ala
225 230 235 240
Gly Thr Thr Leu Thr Val Leu Gly
245
<210> 4
<211> 243
<212> PRT
<213> 鸡(Gallus gallus)
<400> 4
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly
1 5 10 15
Ala Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Asp Phe Ser Ser Tyr
20 25 30
Ala Met Tyr Trp Val Arg Gln Ala Pro Gly Glu Gly Leu Glu Leu Val
35 40 45
Ala Gly Ile Arg Ala Asp Gly Ser Tyr Lys Ser Tyr Gly Ala Ala Val
50 55 60
Lys Gly Arg Ala Thr Ile Ser Arg Asp Asp Gly Gln Ser Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Ala Thr Tyr Phe Cys
85 90 95
Ala Lys Ser Ala Ser Ile Tyr Cys Cys Ala Ala Asp Glu Ile Asp Thr
100 105 110
Trp Gly His Arg Thr Glu Val Ile Val Ser Ser Ala Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Leu Thr Gln
130 135 140
Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Lys Ile Thr Cys
145 150 155 160
Ser Gly Asp Arg Ile Trp Tyr Gly Trp Tyr Gln Gln Lys Ala Leu Cys
165 170 175
Ser Ala Pro Val Thr Val Ile Tyr Asp Asn Thr Asn Arg Pro Ser Asn
180 185 190
Ile Pro Ser Arg Phe Ser Gly Ser Lys Ser Gly Ser Thr Ala Thr Leu
195 200 205
Thr Ile Thr Gly Val Gln Ala Asp Asp Glu Ala Val Tyr Tyr Cys Gly
210 215 220
Ser Tyr Glu Asp Arg Ser Gly Ile Phe Gly Ala Gly Thr Thr Leu Thr
225 230 235 240
Val Leu Gly
<210> 5
<211> 245
<212> PRT
<213> 鸡(Gallus gallus)
<400> 5
Ala Val Thr Leu Asp Glu Pro Gly Gly Gly Leu Gln Met Pro Gly Gly
1 5 10 15
Gly Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Thr Phe Ser Ser Asn
20 25 30
Gly Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Phe Val
35 40 45
Ala Gly Ile Asp Ser Pro Gly Ser Tyr Thr Tyr Tyr Gly Ala Ala Val
50 55 60
Lys Gly Cys Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Gly Ile Tyr Phe Cys
85 90 95
Ala Lys Gly Ala Gly Gly Trp Cys Thr Tyr Gly Cys Ala Asp Glu Ile
100 105 110
Asp Ala Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser Gly
115 120 125
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Leu
130 135 140
Thr Gln Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Lys Ile
145 150 155 160
Thr Cys Ser Gly Gly Ser Ser Ser Tyr Tyr Gly Trp Tyr Gln Gln Lys
165 170 175
Ser Pro Gly Ser Ala Pro Val Thr Leu Ile Tyr Ser Asn Asp Lys Arg
180 185 190
Pro Ser Asp Ile Pro Pro Arg Phe Ser Gly Ser Thr Ser Gly Ser Thr
195 200 205
Ala Thr Leu Thr Ile Thr Gly Val Gln Ala Asp Asp Glu Ala Val Tyr
210 215 220
Tyr Cys Gly Ser Glu Asp Ser Ser Gly Ile Phe Gly Ala Gly Thr Thr
225 230 235 240
Leu Thr Val Leu Gly
245
<210> 6
<211> 246
<212> PRT
<213> 鸡(Gallus gallus)
<400> 6
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly
1 5 10 15
Ala Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Ser Phe Ser Ser Phe
20 25 30
Asn Met Phe Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Tyr Val
35 40 45
Ala Val Ile Ser Ser Asn Asp Gly Ser Trp Thr Ala Tyr Gly Ala Ala
50 55 60
Val Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val
65 70 75 80
Arg Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Ala Thr Tyr Tyr
85 90 95
Cys Ala Lys Ala Ala Asp Pro Ser Gly Pro Ser Gly Ser Ile Asp Ala
100 105 110
Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser Gly Gly Gly
115 120 125
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Leu Thr Gln
130 135 140
Pro Ser Ser Val Ser Ala Asn Pro Gly Glu Thr Val Lys Ile Thr Cys
145 150 155 160
Ser Gly Gly Gly Ser Ser Ser Tyr Tyr Gly Trp Tyr Gln Gln Lys Ser
165 170 175
Pro Gly Ser Ala Pro Val Thr Val Ile Tyr Tyr Asn Gly Lys Arg Pro
180 185 190
Ser Asp Ile Pro Ser Arg Phe Ser Gly Ser Lys Ser Gly Ser Thr Gly
195 200 205
Thr Leu Thr Ile Thr Gly Val Gln Ala Glu Asp Glu Ala Ile Tyr Tyr
210 215 220
Cys Gly Ser Val Asp Gly Ser Ser Thr Ala Ala Phe Gly Ala Gly Thr
225 230 235 240
Ala Leu Thr Val Leu Gly
245
<210> 7
<211> 244
<212> PRT
<213> 鸡(Gallus gallus)
<400> 7
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly
1 5 10 15
Val Leu Ser Leu Val Cys Lys Gly Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Gly Met Gly Trp Met Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Gly Ser Asp Gly Ser Asn Pro Asn Tyr Gly Ala Ala Val
50 55 60
Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Ser Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Gly Thr Tyr Tyr Cys
85 90 95
Ala Lys Arg Gly Ser Ser Asp Ser Tyr Gly Ala Ala Pro Gly Asn Ile
100 105 110
Asp Val Trp Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser Gly
115 120 125
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Leu
130 135 140
Thr Gln Pro Ser Ser Val Ser Ala Asn Leu Gly Gly Thr Val Glu Ile
145 150 155 160
Thr Cys Ser Gly Asp Ser Asn Asn Tyr Gly Trp Tyr Gln Gln Lys Ala
165 170 175
Pro Gly Ser Ala Pro Val Thr Val Ile Tyr Asp Asn Thr Asn Arg Pro
180 185 190
Ser Asn Ile Pro Ser Arg Phe Ser Gly Ser Lys Ser Gly Ser Thr Ala
195 200 205
Thr Leu Thr Ile Thr Gly Val Gln Ala Glu Asp Glu Ala Val Tyr Phe
210 215 220
Cys Gly Thr Tyr Glu Asp Ser Ser Ile Phe Gly Ala Gly Thr Thr Leu
225 230 235 240
Thr Val Leu Gly
<210> 8
<211> 244
<212> PRT
<213> 鸡(Gallus gallus)
<400> 8
Ala Val Thr Leu Asp Glu Ser Gly Gly Gly Leu Gln Thr Pro Gly Gly
1 5 10 15
Ala Leu Ser Leu Val Cys Lys Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ala Gly Ile Arg Asn Thr Gly Arg Tyr Thr Gly Tyr Gly Ser Ala Val
50 55 60
Lys Gly Arg Ala Thr Ile Ser Arg Asp Asn Gly Gln Thr Thr Val Arg
65 70 75 80
Leu Gln Leu Asn Asn Leu Arg Ala Glu Asp Thr Gly Thr Tyr Tyr Cys
85 90 95
Thr Lys Cys Ala Gly Ile Ala Tyr Gly Ala Glu Asp Ile Asp Ala Trp
100 105 110
Gly His Gly Thr Glu Val Ile Val Ser Ser Ala Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Ala Leu Thr Gln Pro
130 135 140
Ser Ser Val Ser Ala Asn Leu Gly Gly Thr Val Glu Ile Thr Cys Ser
145 150 155 160
Gly Gly Gly Gly Ser Tyr Gly Trp Tyr Gln Gln Lys Ser Pro Gly Ser
165 170 175
Ala Pro Val Thr Leu Ile Tyr Ala Asn Thr Asn Arg Pro Ser Asn Ile
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Ser Thr Gly Thr Leu Thr
195 200 205
Ile Thr Gly Val Arg Ala Glu Asp Glu Ala Val Tyr Tyr Cys Gly Ser
210 215 220
Glu Asp Ser Ser Gly Thr Asp Ser Val Phe Gly Ala Gly Thr Thr Leu
225 230 235 240
Thr Val Leu Gly
<210> 9
<211> 747
<212> DNA
<213> 鸡(Gallus gallus)
<400> 9
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccggaggagg gctcagcctc 60
gtctgcaagg cctccgggtt caccatgagc agttatgaca tgctctgggt gcgacaggcg 120
cccggcaagg ggctggagtg ggtcgctggt attaatgctg ctggtagtag cacatggtac 180
gcgacagcgg tgaagggccg tgccaccatc tcgagggaca acgggcagag cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accgccacct acttctgcgt caaagctggt 300
ggtggttgta gtggttacgg ttgtggtagt catgctggtc ggatcgacgc atggggccac 360
gggaccgaag tcatcgtctc ctccgctagc ggtggtggtg gttctggtgg tggtggttct 420
ggtggtggtg gatccgcgct gactcagccg tcctcggtgt cagcgaaccc gggagaaacc 480
gttgagatca cctgctccgg ggatagcagc tactatggct ggtaccagca gaaggcacct 540
ggcagtgccc ctgtcactct gatctatgac aacaccaaca gaccctcgaa catcccttca 600
cgattctccg gttccaaatc cggctccaca gccacattaa ccatcactgg ggtccaagcc 660
gacgacgagg ctgtctatta ctgtgggagt gcagacagca gcactgctac atttggggcc 720
gggacaaccc tgaccgtcct aggttaa 747
<210> 10
<211> 744
<212> DNA
<213> 鸡(Gallus gallus)
<400> 10
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccagaggagc gctcagcctc 60
gtctgcaagg gctccgggtt caccttcagc agttatgcca tgaactgggt gcgacaggcg 120
cccggcaaag ggctggagtg ggtcgctggt gttagcggca gtggtggtag cacagcatac 180
gggtcggcgg tgaagggccg tgccaccatc tcgagggaca acgggcagag cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accgccacct actactgcgc caaaactgct 300
agttactgtt atagtgctgc ttgtactgct gctaccatcg acgcatgggg ccacgggacc 360
gaagtcatcg tctcctccgc tagcggtggt ggtggttctg gtggtggtgg ttctggtggt 420
ggtggatccg cgctgactca gccgtcctcg gtgtcagcga acccgggaga aaccgtcaag 480
atcacctgct ccgggggtgg cagctactat ggctggtacc agcagaagtc tcctggcagt 540
gcccctgtca ctgtgatcta tgacaacaac cagagaccct cgaacatccc ttcacgattc 600
tccggttcca catctggctc cacaagcaca ttaaccatca ctggggtcca agccgacgac 660
gaggctgtct attactgtgg gagttacgac agcagtggtg atggtacatt tggggccggg 720
acaaccctga ccgtcctagg ttaa 744
<210> 11
<211> 747
<212> DNA
<213> 鸡(Gallus gallus)
<400> 11
gccgtgacgt tggacgagcc cgggggtggc ctccagatgc ctggaggagg gctcagcctc 60
gtctgcaagg cctccgggtt cgacttcagc agttacgcca tgatgtgggt gcgacaggcg 120
ccccgcaagg ggcttgaatt cgtcggctat gttaatattg atagttggac agcatacggg 180
gcggcggtga agggccgtgc caccatctcg agggacaacg ggcagagcac ggtgaggctg 240
cagctgaaca acctcagggc tgaggacacc gccatctact actgcgccaa gggtgcttat 300
aattattgtg gtcggaatta tgtgaatact ggttgcatcg acgcatgggg ccacgggacc 360
gaagtcatcg tctcctccgc tagcggtggt ggtggttctg gtggtggtgg ttctggtggt 420
ggtggatccg cgctgactca gccgtcctcg gtgtcagcga acccgggaga aaccgttgag 480
atcgcctgct ccgggggtag cagctactat ggctggttcc agcagaaggc acctggcagt 540
gcccctgtca ctgtgatcta tgacaacacc aacagaccct cggacatccc ttcacgattc 600
tccggttccc tatccggctc cacaaacaca ttaaccatca ctggggtcca ggccgatgac 660
gaggctgtct atttctgtgg gagtgaagac agcagcagct atgctggtat atttggggcc 720
gggacaaccc tgaccgtcct aggttaa 747
<210> 12
<211> 732
<212> DNA
<213> 鸡(Gallus gallus)
<400> 12
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccggaggagc gctcagcctc 60
gtctgcaagg cctccgggtt cgacttcagc agttacgcca tgtactgggt gcgacaggcg 120
cccggcgagg ggctggagct cgtcgcgggt attagagctg atggtagtta caaaagctac 180
ggggcggcgg tgaagggccg tgccaccatc tcgagggacg acgggcagag cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accgccacct acttctgcgc caaaagtgct 300
agtatttatt gttgtgctgc tgatgagatc gacacatggg gccacaggac cgaagtcatc 360
gtctcctccg ctagcggtgg tggtggttct ggtggtggtg gttctggtgg tggtggatcc 420
gcgctgactc agccgtcctc ggtgtcagcg aacccgggag aaaccgtcaa gatcacctgc 480
tccggggata ggatctggta tggctggtat cagcagaagg cactttgcag tgcccctgtc 540
actgtgattt atgacaacac caacagaccc tcgaacatcc cttcacgatt ctccggttcc 600
aaatccggct ccacagccac attaaccatc actggggtcc aagccgacga cgaggctgtc 660
tattattgtg ggagctacga agacaggagt ggcatatttg gggccgggac aaccctgacc 720
gtcctaggtt aa 732
<210> 13
<211> 738
<212> DNA
<213> 鸡(Gallus gallus)
<400> 13
gccgtgacgt tggacgagcc cgggggcggc ctccagatgc ccggaggagg gctcagcctc 60
gtctgcaagg cctccgggtt caccttcagc agtaatggca tggcctgggt gcgacaggcg 120
cccggcaagg ggctggagtt cgtcgctggt attgatagcc ctggtagtta cacatactac 180
ggggcggcgg tgaagggctg tgccaccatc tcgagggaca acgggcagag cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accggcatct acttctgcgc caaaggtgct 300
ggtggttggt gtacttatgg ttgtgctgat gagatcgacg catggggcca cgggaccgaa 360
gtcatcgtct cctccgctag cggtggtggt ggttctggtg gtggtggttc tggtggtggt 420
ggatccgcgc tgactcagcc gtcctcggtg tcagcaaacc cgggagaaac cgtcaagatc 480
acctgctccg ggggtagcag cagctactat ggctggtacc agcagaagtc tccaggcagt 540
gcccctgtca ctctgatcta tagcaacgac aagagaccct cggacatccc tccacgattc 600
tccggttcca catccggctc cacagccaca ttaaccatca ctggggtcca agccgacgac 660
gaggctgtct attactgtgg gagtgaagac agcagtggca tatttggggc cgggacaacc 720
ctgaccgtcc taggttaa 738
<210> 14
<211> 741
<212> DNA
<213> 鸡(Gallus gallus)
<400> 14
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccggaggagc gctcagcctc 60
gtctgcaagg cctccgggtt ctccttcagc agcttcaaca tgttctgggt gcgacaggct 120
cccggcaagg ggctggaata tgtcgcagtt attagcagca atgatggtag ttggacagca 180
tacggggcgg cggtgaaggg ccgtgccacc atctcgaggg acaacgggca gagcacagtg 240
aggctgcagc tgaacaacct cagggctgag gacaccgcca cctactactg cgccaaagct 300
gctgatccta gtggtccttc tggtagcatc gacgcatggg gccacgggac cgaagtcatc 360
gtctcctccg ctagcggtgg tggtggttct ggtggtggtg gttctggtgg tggtggatcc 420
gcgctgactc agccgtcctc ggtgtcagca aacccaggag aaaccgtcaa gatcacctgc 480
tccgggggtg gtagcagcag ctactatggc tggtaccagc agaagtctcc tggcagtgcc 540
cctgtcactg tgatctatta taacggcaag agaccctcgg acatcccttc acgattctcc 600
ggttccaaat ccggctccac gggcacatta accatcactg gggtccaagc cgaggacgag 660
gctatctatt actgtgggag tgtagacggc agcagtactg ctgcatttgg ggccgggaca 720
gccctgaccg tcctaggtta a 741
<210> 15
<211> 735
<212> DNA
<213> 鸡(Gallus gallus)
<400> 15
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccggaggagt gctcagcctc 60
gtctgcaagg gctccgggtt caccttcagc agttacggca tgggttggat gcgccaggca 120
cccggcaagg ggctggagtg ggtcgctggt attggaagtg atggtagtaa cccaaactac 180
ggggcagcgg tgaagggccg tgccaccatc tcgagggaca acgggcagag cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accggcacct actactgcgc caaacgtggt 300
tccagtgata gttatggtgc tgctcctggt aacatcgacg tatggggcca cgggaccgaa 360
gtcatcgtct cctccgctag cggtggtggt ggttctggtg gtggtggttc tggtggtggt 420
ggatccgcgc tgactcagcc gtcctcggtg tcagcaaacc tgggaggaac cgtcgagatc 480
acctgctccg gggatagcaa caactatggc tggtaccagc agaaggcacc tggcagtgcc 540
cctgtcactg tgatctatga caacaccaac agaccctcga acatcccttc acgattctcc 600
ggttccaaat ccggctccac agccacatta accatcactg gggtccaagc cgaggacgag 660
gctgtctatt tctgtgggac ctacgaagac agcagtatat ttggggccgg gacaaccctg 720
accgtcctag gttaa 735
<210> 16
<211> 735
<212> DNA
<213> 鸡(Gallus gallus)
<400> 16
gccgtgacgt tggacgagtc cgggggcggc ctccagacgc ccggaggagc gctcagcctc 60
gtctgcaagg cctctgggtt caccttcagc agttacgcca tgaactgggt gcgacaggcg 120
cccggcaagg ggctggagtg ggtcgcaggt attcgcaaca ctggtagata cacaggctac 180
gggtcggcgg tgaagggccg tgccaccatc tcgagggaca acgggcagac cacagtgagg 240
ctgcagctga acaacctcag ggctgaggac accggcacct actactgcac gaaatgtgct 300
ggtattgctt acggtgctga agatatcgac gcatggggcc acgggaccga agtcatcgtc 360
tcctccgcta gcggtggtgg tggttctggt ggtggtggtt ctggtggtgg tggatccgcg 420
ctgactcagc cgtcctcggt gtcagcaaac ctgggaggaa ccgtcgagat cacctgctcc 480
gggggtggtg gcagctacgg ctggtatcag cagaagtcac ctggcagtgc ccctgtcact 540
ctgatctatg ctaacaccaa cagaccctca aacatccctt cacgattctc cggttctgga 600
tccggctcca caggcacatt aaccatcact ggggtccgag ccgaggacga ggctgtctat 660
tactgtggga gtgaagacag cagcggtact gatagtgtat ttggggccgg gacaaccctg 720
accgtcctag gttaa 735
Claims (6)
1.几种单链抗体(scFv抗体)，单链抗体包括由重链可变区、轻链可变区以及它们之间的连接区组成；
所述scFv-11为如下(a)：(a)由序列表中序列1自N末端第1-248位氨基酸残基组成的蛋白质；
所述scFv-12为如下(b)：(b)由序列表中序列2自N末端第1-247位氨基酸残基组成的蛋白质；
所述scFv-13为如下(c)：(c)由序列表中序列3自N末端第1-248位氨基酸残基组成的蛋白质；
所述scFv-14为如下(d)：(d)由序列表中序列4自N末端第1-243位氨基酸残基组成的蛋白质；
所述scFv-15为如下(e)：(e)由序列表中序列5自N末端第1-245位氨基酸残基组成的蛋白质；
所述scFv-16为如下(f)：(f)由序列表中序列6自N末端第1-246位氨基酸残基组成的蛋白质；
所述scFv-17为如下(g)：(g)由序列表中序列7自N末端第1-244位氨基酸残基组成的蛋白质；
所述scFv-18为如下(h)：(h)由序列表中序列8自N末端第1-244位氨基酸残基组成的蛋白质。
2.编码权利要求1所述单链抗体的基因。
3.如权利要求2所述的基因，其特征在于：
所述基因中，编码所述scFv-11的DNA分子为如下(1)：(1)序列表的序列9自5’末端第1-747位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-12的DNA分子为如下(2)：(2)序列表的序列10自5’末端第1-744位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-13的DNA分子为如下(3)：(3)序列表的序列11自5’末端第1-747位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-14的DNA分子为如下(4)：(4)序列表的序列12自5’末端第1-732位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-15的DNA分子为如下(5)：(5)序列表的序列13自5’末端第1-738位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-16的DNA分子为如下(6)：(6)序列表的序列14自5’末端第1-741位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-17的DNA分子为如下(7)：(7)序列表的序列15自5’末端第1-735位核苷酸所示的DNA分子；
所述基因中，编码所述scFv-18的DNA分子为如下(8)：(8)序列表的序列16自5’末端第1-735位核苷酸所示的DNA分子。
4.含有权利要求2至3中任一所述基因的表达盒、重组载体、转基因细胞系或重组菌。
5.基于权利要求1所述单链抗体的突变体和/或1个和/或几个氨基酸残基替换的其它形式的具有相同功能的抗体。
6.权利要求1-5所述的单链抗体在制备产品中的应用；所述产品的功能为如下(Ⅰ)和/或(Ⅱ)和/或(Ⅲ)和/或(Ⅳ)：(Ⅰ)检测鸡传染性法氏囊病病毒；(Ⅱ)辅助鉴定鸡传染性法氏囊病病毒；(Ⅲ)预防和/或治疗鸡传染性法氏囊病；(Ⅳ)预防和/或治疗由鸡传染性法氏囊病病毒诱发的疾病。
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111522402.4A CN114213532B (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608002.8A CN117843770A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608000.9A CN117843769A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607996.1A CN117843766A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607998.0A CN117843767A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607999.5A CN117843768A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608001.3A CN118240070A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608003.2A CN117843771A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111522402.4A CN114213532B (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Related Child Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310607998.0A Division CN117843767A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607996.1A Division CN117843766A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608000.9A Division CN117843769A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608003.2A Division CN117843771A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608001.3A Division CN118240070A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608002.8A Division CN117843770A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607999.5A Division CN117843768A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114213532A true CN114213532A (zh) | 2022-03-22 |
| CN114213532B CN114213532B (zh) | 2023-06-13 |
Family
ID=80701608
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310608000.9A Pending CN117843769A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607996.1A Pending CN117843766A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607999.5A Pending CN117843768A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202111522402.4A Active CN114213532B (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608002.8A Pending CN117843770A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607998.0A Pending CN117843767A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608001.3A Pending CN118240070A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608003.2A Pending CN117843771A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310608000.9A Pending CN117843769A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607996.1A Pending CN117843766A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607999.5A Pending CN117843768A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310608002.8A Pending CN117843770A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310607998.0A Pending CN117843767A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608001.3A Pending CN118240070A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
| CN202310608003.2A Pending CN117843771A (zh) | 2021-12-13 | 2021-12-13 | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (8) | CN117843769A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113493509A (zh) * | 2021-07-23 | 2021-10-12 | 东北农业大学 | 抗鸡传染性法氏囊病毒的四价高亲和力抗体及其制备和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7449556B2 (en) * | 2001-06-05 | 2008-11-11 | Commonwealth Scientific And Industrial Organisation | Recombinant antibodies against infectious bursal disease virus (ibdv) |
| CN103333242A (zh) * | 2013-07-23 | 2013-10-02 | 哈尔滨博翱生物医药技术开发有限公司 | scFv抗体、其编码基因及其在制备治疗或预防鸡传染性法氏囊病制剂中的应用 |
| CN103483449A (zh) * | 2013-08-20 | 2014-01-01 | 东北农业大学 | 两种scFv抗体、其编码基因及其在制备治疗或预防鸡传染性法氏囊病制剂中的应用 |
| CN105384815A (zh) * | 2015-12-03 | 2016-03-09 | 哈尔滨博翱生物医药技术开发有限公司 | 一种scFv抗体在治疗或预防鸡传染性法氏囊病制剂中的应用 |
| US20210189010A1 (en) * | 2018-09-05 | 2021-06-24 | Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited | Development of recombinant chicken igy scfv antibody raised against human tymidine kinase 1 expressed in prokaryotic cells and use thereof |
-
2021
- 2021-12-13 CN CN202310608000.9A patent/CN117843769A/zh active Pending
- 2021-12-13 CN CN202310607996.1A patent/CN117843766A/zh active Pending
- 2021-12-13 CN CN202310607999.5A patent/CN117843768A/zh active Pending
- 2021-12-13 CN CN202111522402.4A patent/CN114213532B/zh active Active
- 2021-12-13 CN CN202310608002.8A patent/CN117843770A/zh active Pending
- 2021-12-13 CN CN202310607998.0A patent/CN117843767A/zh active Pending
- 2021-12-13 CN CN202310608001.3A patent/CN118240070A/zh active Pending
- 2021-12-13 CN CN202310608003.2A patent/CN117843771A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7449556B2 (en) * | 2001-06-05 | 2008-11-11 | Commonwealth Scientific And Industrial Organisation | Recombinant antibodies against infectious bursal disease virus (ibdv) |
| CN103333242A (zh) * | 2013-07-23 | 2013-10-02 | 哈尔滨博翱生物医药技术开发有限公司 | scFv抗体、其编码基因及其在制备治疗或预防鸡传染性法氏囊病制剂中的应用 |
| CN103483449A (zh) * | 2013-08-20 | 2014-01-01 | 东北农业大学 | 两种scFv抗体、其编码基因及其在制备治疗或预防鸡传染性法氏囊病制剂中的应用 |
| CN105384815A (zh) * | 2015-12-03 | 2016-03-09 | 哈尔滨博翱生物医药技术开发有限公司 | 一种scFv抗体在治疗或预防鸡传染性法氏囊病制剂中的应用 |
| US20210189010A1 (en) * | 2018-09-05 | 2021-06-24 | Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited | Development of recombinant chicken igy scfv antibody raised against human tymidine kinase 1 expressed in prokaryotic cells and use thereof |
Non-Patent Citations (6)
| Title |
|---|
| LI,T. 等: ""immunoglobulin single chain variable fragment, partial [synthetic construct]"", 《GENBANK》 * |
| SAPATS,S.I. 等: "\"Synthetic construct immunoglobulin G scFv antibody CRAb66 mRNA, partial cds\"", 《GENBANK》 * |
| XIAOCHEN GUO 等: ""Screening scFv antibodies against infectious bursal disease virus by co-expression of antigen and antibody in the bacteria display system"", 《VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY》 * |
| YINGJIE ZHANG 等: ""A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection"", 《RES VET SCI》 * |
| 周兵 等: ""抗鸡传染性法氏囊病病毒单链抗体库的构建及其中和抗体的筛选"", 《中国预防兽医学报》 * |
| 张瑛杰 等: ""抗鸡传染性法氏囊病病毒抗体Fab的表达及其中和活性的测定"", 《中国预防兽医学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113493509A (zh) * | 2021-07-23 | 2021-10-12 | 东北农业大学 | 抗鸡传染性法氏囊病毒的四价高亲和力抗体及其制备和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117843769A (zh) | 2024-04-09 |
| CN117843771A (zh) | 2024-04-09 |
| CN117843770A (zh) | 2024-04-09 |
| CN118240070A (zh) | 2024-06-25 |
| CN117843768A (zh) | 2024-04-09 |
| CN117843766A (zh) | 2024-04-09 |
| CN114213532B (zh) | 2023-06-13 |
| CN117843767A (zh) | 2024-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Foord et al. | Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC | |
| CN108892723B (zh) | 用于检测猪流行性腹泻病毒的单域重链抗体、制备方法及应用 | |
| CN110845605B (zh) | 一种抗犬细小病毒的基因工程抗体及其应用 | |
| CN111269318A (zh) | 一种gapdh纳米抗体及其应用 | |
| CN110373393B (zh) | 一种分泌抗传染性法氏囊病毒vp2蛋白单克隆抗体的杂交瘤细胞株1h6 | |
| CN114213532B (zh) | 高亲和力的抗鸡传染性法氏囊病毒的scFv抗体的制备及其应用 | |
| CN108659124B (zh) | 一种抗猪流行性腹泻病毒的单链抗体及其应用 | |
| CN117106080B (zh) | 人源抗鼠疫耶尔森菌LcrV的抗体及其相关产品和用途 | |
| EP0575410A1 (en) | The biological selection of useful molecules | |
| CN108982847B (zh) | 一种导致鸭脾脏坏死的鸭呼肠孤病毒的间接elisa检测方法 | |
| CN114605526B (zh) | 一种针对腺病毒载体的单域重链抗体及其应用 | |
| CN114316040B (zh) | 一种抗新型冠状病毒的全人源单克隆抗体及其用途 | |
| Xu et al. | Recombinant scFv antibodies against infectious pancreatic necrosis virus isolated by flow cytometry | |
| CN114195889A (zh) | 一种SARS-Cov-2-N纳米抗体及其衍生蛋白和应用 | |
| CN113402603A (zh) | 一种抗SARS-CoV-2病毒S1蛋白的禽源单链抗体及其应用 | |
| Savinov et al. | Search for ligand of N-acetylglucosaminyl-N-acetylmuramyl dipeptide using its peptide mimetic | |
| WO2011114353A1 (en) | Monovalent human anti-hepatitis a virus antibody and uses thereof | |
| CN114106170B (zh) | 一种抗大田软海绵酸单链抗体的氨基酸序列及其表达载体 | |
| CN114276447B (zh) | 一种牛源抑制金黄色葡萄球菌生长的单链抗体及其制备方法和用途 | |
| CN112608383B (zh) | 一种抗牙鲆弹状病毒的单链抗体 | |
| CN117164705B (zh) | 一种靶向h5亚型禽流感病毒血凝素蛋白的纳米抗体 | |
| CN114891098B (zh) | 一种产气荚膜梭菌β毒素纳米抗体及其应用 | |
| CN111499734B (zh) | 一种抗鸭圆环病毒的单链抗体及其制备方法和应用 | |
| WO2008083432A1 (en) | Recombinant antibodies | |
| CN116693665A (zh) | 基于gB蛋白的检测猫疱疹病毒的抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |